Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1HOVIONE FARMACIENCIA SA

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

QUIZARTINIB DIHYDROCHLORIDE

NDC Package Code : 50909-1915

Start Marketing Date : 2023-07-20

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (12.73kg/140kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

Looking for 950769-58-1 / Quizartinib API manufacturers, exporters & distributors?

Quizartinib manufacturers, exporters & distributors 1

67

PharmaCompass offers a list of Quizartinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Quizartinib manufacturer or Quizartinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Quizartinib manufacturer or Quizartinib supplier.

PharmaCompass also assists you with knowing the Quizartinib API Price utilized in the formulation of products. Quizartinib API Price is not always fixed or binding as the Quizartinib Price is obtained through a variety of data sources. The Quizartinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Quizartinib

Synonyms

950769-58-1, Ac220, Quizartinib (ac220), Ac-220, Ac 220, Quizartinib hcl

Cas Number

950769-58-1

Unique Ingredient Identifier (UNII)

7LA4O6Q0D3

About Quizartinib

Quizartinib is an orally available small molecule with potential antineoplastic activity. Quizartinib selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3 (FLT3/STK1), colony-stimulating factor 1 receptor (CSF1R/FMS), stem cell factor receptor (SCFR/KIT), and platelet derived growth factor receptors (PDGFRs), resulting in inhibition of ligand-independent leukemic cell proliferation and apoptosis. Mutations in FLT3, resulting in constitutive activation, are the most frequent genetic alterations in acute myeloid leukemia (AML) and occur in approximately one-third of AML cases.

Quizartinib Manufacturers

A Quizartinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quizartinib, including repackagers and relabelers. The FDA regulates Quizartinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quizartinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Quizartinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Quizartinib Suppliers

A Quizartinib supplier is an individual or a company that provides Quizartinib active pharmaceutical ingredient (API) or Quizartinib finished formulations upon request. The Quizartinib suppliers may include Quizartinib API manufacturers, exporters, distributors and traders.

click here to find a list of Quizartinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Quizartinib NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Quizartinib as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Quizartinib API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Quizartinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Quizartinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Quizartinib NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Quizartinib suppliers with NDC on PharmaCompass.

Quizartinib Manufacturers | Traders | Suppliers

Quizartinib Manufacturers, Traders, Suppliers 1
25

We have 1 companies offering Quizartinib

Get in contact with the supplier of your choice:

  1. Hovione
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.